Restasis and Colitis ischaemic - a phase IV clinical study of FDA data

Summary:

Colitis ischaemic is reported as a side effect among people who take Restasis (cyclosporine), especially for people who are female, 60+ old, also take Acetaminophen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Colitis ischaemic when taking Restasis. It is created by eHealthMe based on reports of 34,716 people who have side effects when taking Restasis from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Colitis ischaemic?

Colitis ischaemic (due to infection of intestine impaired blood supply to colon) is found to be associated with 801 drugs and 835 conditions by eHealthMe. Check the latest studies of Colitis ischaemic.

On Jul, 17, 2026

34,716 people reported to have side effects when taking Restasis.
Among them, 17 people (0.05%) have Colitis ischaemic.

Among these 17 people:

What is the gender of people who have Colitis ischaemic when taking Restasis? *

female: 94.12 %
male: 5.88 %

What is the age of people who have Colitis ischaemic when taking Restasis? *

What are other drugs people take besides Restasis? *

Acetaminophen: 11 people, 64.71%
Potassium: 10 people, 58.82%
Fluconazole: 9 people, 52.94%
Epinephrine: 9 people, 52.94%
Diphenhydramine Hydrochloride: 8 people, 47.06%
Calcium: 7 people, 41.18%
Fish Oil: 7 people, 41.18%
Nystatin: 6 people, 35.29%
Lidocaine: 6 people, 35.29%
Incruse Ellipta: 6 people, 35.29%

What are other side effects people have besides Colitis ischaemic? *

Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 6 people, 35.29%
Urinary Tract Infection: 6 people, 35.29%
Blood Immunoglobulin G Abnormal: 6 people, 35.29%
Blood Iron Abnormal: 6 people, 35.29%
Haemorrhage Urinary Tract (bleeding from uterine): 6 people, 35.29%
Pneumonia: 6 people, 35.29%
Diarrhea: 6 people, 35.29%
Foot Deformity (functional disability of foot): 6 people, 35.29%
Vitamin B12 Decreased: 6 people, 35.29%
Mycobacterium Avium Complex Infection: 5 people, 29.41%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 52.94%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Rickets (softening of bones): 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Bone Loss: 1 person, 5.88%
Delusion (a false belief or opinion): 1 person, 5.88%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 5.88%
Hair Loss: 1 person, 5.88%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and have Colitis ischaemic?

- Check whether Colitis ischaemic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Restasis:

Restasis (35,199 reports)

Browse all side effects of Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Colitis ischaemic:

Colitis ischaemic (801 drugs)

Browse all the conditions that are associated with Colitis ischaemic:

Colitis ischaemic (835 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Tan J, Pretorius CF, Flanagan PV, Pais A, "Unexpected outcome (positive or negative) including adverse drug reactions: Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman", BMJ Case Reports, 2013 Jan .
Tan J, Pretorius CF, Flanagan PV, Pais A, "Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman", BMJ case reports, 2012 Jun .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Tan J, Pretorius CF, Flanagan PV, Pais A, "Unexpected outcome (positive or negative) including adverse drug reactions: Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman", BMJ Case Reports, 2013 Jan .
Tan J, Pretorius CF, Flanagan PV, Pais A, "Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman", BMJ case reports, 2012 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Restasis) and Restasis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.